Global Blood Therapeutics
Get Full AccessDescription
- Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.GBT is developing its lead product candidate, GBT440, as an oral, once-daily therapy for sickle cell disease (SCD) and is currently evaluating GBT440 in a pivotal Phase 3 study. GBT is also investigating GBT440 for the treatment of hypoxemic pulmonary disorders in an ongoing Phase 2a study in patients with idiopathic pulmonary fibrosis.
-
Headquarters:400 East Jamie Court Suite 101, South San Francisco, California, United States
More -
Phone Number: +1 650-741-7700
-
Website: https://www.globalbloodtx.com
-
Employees:74
-
Revenue:$50 - 100M
-
Legal Name:Global Blood Therapeutics
-
Global Blood Therapeutics's Social Media
-
Is this data correct?
-
| NAICS Code: 621511 |
Show More
Frequently Asked Questions regarding Global Blood Therapeutics
-
Where are Global Blood Therapeutics's Headquarters?
Global Blood Therapeutics's Headquarters are in 400 East Jamie Court Suite 101,South San Francisco,California,United States
-
What is Global Blood Therapeutics's phone number?
Global Blood Therapeutics's phone number is +1 650-741-7700
-
What is Global Blood Therapeutics's official website?
Global Blood Therapeutics's official website is https://www.globalbloodtx.com
-
What is Global Blood Therapeutics's Revenue?
Global Blood Therapeutics's revenue is $50 - 100M
-
What is Global Blood Therapeutics's NAICS code?
Global Blood Therapeutics's NAICS code is 621511
-
How many employees are working in Global Blood Therapeutics
Global Blood Therapeutics has 74 employees
-
What is Global Blood Therapeutics's Industry?
Global Blood Therapeutics is in the industry of Biotechnology
-
Who is Global Blood Therapeutics's CEO?
Global Blood Therapeutics's CEO is Ted Love

